ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Nath Bio-Genes reported strong Q1 FY27 results with Revenue and EBITDA growing 15% and 17% YoY respectively. The company continues to focus on high-yield cotton, maize, and paddy seeds.
Nath Bio-Genes reported FY26 revenue of ₹4,316M (up 19% YoY) with an EBITDA of ₹525M. Management is diversifying into non-cotton, non-paddy segments (NCD) and international markets like Uzbekistan.
Nath Bio-Genes reported strong FY26 performance with 19% revenue growth and international expansion into Uzbekistan. Strategy focused on core Cotton/Paddy crops and premium seed varieties.
Nath Bio-Genes reported FY26 revenue of ₹4,316 Mn, a 19% YoY increase, driven by strong growth in Cotton, Paddy, and Maize segments. Strategy focuses on R&D, product diversification, and international expansion.